Nuvation Bio Inc.: net income or loss
Net income or loss for Nuvation Bio Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Nuvation Bio Inc. financial histories
What this measure means
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
Exact concept: us-gaap:NetIncomeLoss. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2020-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | -204,627,000 | USD | 2026-03-02 | 10-K · 0001193125-26-085584 |
| 2024-01-01 | 2024-12-31 | -567,939,000 | USD | 2026-03-02 | 10-K · 0001193125-26-085584 |
| 2023-01-01 | 2023-12-31 | -75,802,000 | USD | 2025-03-06 | 10-K · 0000950170-25-034903 |
| 2022-01-01 | 2022-12-31 | -104,199,000 | USD | 2024-02-29 | 10-K · 0000950170-24-023247 |
| 2021-01-01 | 2021-12-31 | -86,848,000 | USD | 2023-03-15 | 10-K · 0000950170-23-008180 |
| 2020-01-01 | 2020-12-31 | -41,659,000 | USD | 2022-02-28 | 10-K · 0000950170-22-002332 |
Related financial histories
- Nuvation Bio Inc.: total assets
- Nuvation Bio Inc.: total liabilities
- Nuvation Bio Inc.: stockholders equity
- Nuvation Bio Inc.: cash and cash equivalents
- Nuvation Bio Inc.: operating cash flow
- Nuvation Bio Inc.: contract revenue excluding tax
- Nuvation Bio Inc.: financing cash flow
- Nuvation Bio Inc.: investing cash flow
- Nuvation Bio Inc.: retained earnings or deficit
- Nuvation Bio Inc.: basic weighted-average shares
- Nuvation Bio Inc.: diluted weighted-average shares
- Nuvation Bio Inc.: basic earnings per share
- Nuvation Bio Inc.: diluted earnings per share
- Nuvation Bio Inc.: net property, plant and equipment
- Nuvation Bio Inc.: share-based compensation expense
- Nuvation Bio Inc.: operating income or loss
- Nuvation Bio Inc.: current assets
- Nuvation Bio Inc.: current liabilities
- Nuvation Bio Inc.: current accounts payable
- Nuvation Bio Inc.: net finite-lived intangible assets
- Nuvation Bio Inc.: operating expenses
- Nuvation Bio Inc.: selling, general and administrative expense
- Nuvation Bio Inc.: research and development expense
Inspect the source
- Entity
- Nuvation Bio Inc. / CIK 0001811063
- Captured
- 2026-09-21T17:33:50.368Z
- SEC response SHA-256
5e2c6f5309b87f309bb90aca40aa13269796a605da25702d77f834550f311758
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001811063.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))